Marek Krzystanek

1.6k total citations
110 papers, 1.0k citations indexed

About

Marek Krzystanek is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Marek Krzystanek has authored 110 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Psychiatry and Mental health, 17 papers in Cellular and Molecular Neuroscience and 15 papers in Pharmacology. Recurrent topics in Marek Krzystanek's work include Schizophrenia research and treatment (13 papers), Tryptophan and brain disorders (12 papers) and Treatment of Major Depression (11 papers). Marek Krzystanek is often cited by papers focused on Schizophrenia research and treatment (13 papers), Tryptophan and brain disorders (12 papers) and Treatment of Major Depression (11 papers). Marek Krzystanek collaborates with scholars based in Poland, United Kingdom and Italy. Marek Krzystanek's co-authors include K. Krysta, Artur Pałasz, I. Krupka-Matuszczyk, Ryszard Wiaderkiewicz, John J. Worthington, Mateusz Jankowski, Jan Zejda, Joshua Lawson, Grzegorz Brożek and Paulina Majek and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Marek Krzystanek

95 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Krzystanek Poland 17 177 156 143 141 134 110 1.0k
Chi‐Fa Hung Taiwan 21 182 1.0× 83 0.5× 112 0.8× 77 0.5× 182 1.4× 67 1.1k
Ida Hageman Denmark 22 101 0.6× 289 1.9× 98 0.7× 91 0.6× 222 1.7× 82 1.3k
Nicholas Graham United Kingdom 19 476 2.7× 161 1.0× 210 1.5× 167 1.2× 205 1.5× 28 1.7k
Erin L. Zelinski Canada 14 115 0.6× 207 1.3× 76 0.5× 79 0.6× 63 0.5× 17 815
Joel Erblich United States 28 316 1.8× 46 0.3× 179 1.3× 124 0.9× 185 1.4× 62 1.7k
Mandana Ashrafi Iran 22 169 1.0× 111 0.7× 286 2.0× 113 0.8× 260 1.9× 31 2.2k
Monika Talarowska Poland 25 191 1.1× 63 0.4× 302 2.1× 100 0.7× 417 3.1× 136 2.0k
Misty Richards United States 17 199 1.1× 75 0.5× 244 1.7× 134 1.0× 147 1.1× 45 1.4k
Sarah Hartley France 20 183 1.0× 268 1.7× 46 0.3× 106 0.8× 143 1.1× 86 1.1k
Glenna Brewster United States 17 120 0.7× 63 0.4× 303 2.1× 83 0.6× 164 1.2× 47 1.2k

Countries citing papers authored by Marek Krzystanek

Since Specialization
Citations

This map shows the geographic impact of Marek Krzystanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Krzystanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Krzystanek more than expected).

Fields of papers citing papers by Marek Krzystanek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Krzystanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Krzystanek. The network helps show where Marek Krzystanek may publish in the future.

Co-authorship network of co-authors of Marek Krzystanek

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Krzystanek. A scholar is included among the top collaborators of Marek Krzystanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Krzystanek. Marek Krzystanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pałasz, Artur, et al.. (2025). Ferroptosis as a Form of Cell Death—Medical Importance and Pharmacological Implications. Pharmaceuticals. 18(8). 1183–1183.
2.
Madej, Paweł, et al.. (2024). Sexual Function in Women with Polycystic Ovary Syndrome Living in Stable Heterosexual Relationships: A Cross-Sectional Study. Journal of Clinical Medicine. 13(8). 2227–2227. 1 indexed citations
3.
Krzystanek, Marek, et al.. (2024). Effectiveness of health education in forensic psychiatry departments. Psychiatria Polska. 59(4). 1–16.
4.
Krysta, K., et al.. (2023). The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD. Pharmaceuticals. 16(9). 1292–1292. 5 indexed citations
5.
Krzystanek, Marek, et al.. (2023). Depressive and Other Adverse CNS Effects of Fluoroquinolones. Pharmaceuticals. 16(8). 1105–1105. 16 indexed citations
6.
7.
8.
Górski, Michał, et al.. (2023). The Impact of Health Education on the Quality of Life of Patients Hospitalized in Forensic Psychiatry Wards. International Journal of Environmental Research and Public Health. 20(5). 4533–4533. 1 indexed citations
9.
Krysta, K., et al.. (2023). The correlation beteen lifestyle and risk of metabolic syndrome in schizophrenia. European Psychiatry. 66(S1). S1066–S1066. 1 indexed citations
10.
Bąk‐Sosnowska, Monika, et al.. (2022). Exercise addiction symptoms and mental health during the forced exercises deprivation in greatest COVID-19 pandemic restrictions in Poland. Psychiatria Polska. 58(1). 153–168. 1 indexed citations
11.
Pałasz, Artur, et al.. (2021). Olanzapine Increases Neural Chemorepulsant—Draxin Expression in the Adult Rat Hippocampus. Pharmaceuticals. 14(4). 298–298. 2 indexed citations
12.
Pałasz, Artur, et al.. (2021). Modulatory effect of olanzapine on SMIM20/phoenixin, NPQ/spexin and NUCB2/nesfatin-1 gene expressions in the rat brainstem. Pharmacological Reports. 73(4). 1188–1194. 10 indexed citations
13.
Pałasz, Artur, et al.. (2021). Chlorpromazine affects the numbers of Sox-2, Musashi1 and DCX-expressing cells in the rat brain subventricular zone. Pharmacological Reports. 73(4). 1164–1169. 2 indexed citations
14.
Pałasz, Artur, et al.. (2021). Antipsychotics increase steroidogenic enzyme gene expression in the rat brainstem. Molecular Biology Reports. 49(2). 1601–1608. 1 indexed citations
15.
Sztupinszki, Zsófia, Miklós Dióssy, Marek Krzystanek, et al.. (2020). Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations. Clinical Cancer Research. 26(11). 2673–2680. 56 indexed citations
16.
Krzystanek, Marek, et al.. (2018). Telemedyczna terapia poznawczo-behawioralna. Psychiatria. 15(2). 110–116. 1 indexed citations
17.
Krzystanek, Marek, et al.. (2016). Zakupoholizm — nowe wyzwanie terapeutyczne. Psychiatria. 13(3). 149–152. 1 indexed citations
18.
Krysta, K., Marek Krzystanek, Agnieszka Bratek, & I. Krupka-Matuszczyk. (2015). Sleep and inflammatory markers in different psychiatric disorders. Journal of Neural Transmission. 124(S1). 179–186. 41 indexed citations
19.
Krzystanek, Marek, Ewa Krzystanek, Henryk I. Trzeciak, et al.. (2013). Effects of olanzapine and paroxetine on phospholipase D activity in the rat brain. Pharmacological Reports. 65(3). 724–729. 2 indexed citations
20.
Janas–Kozik, Małgorzata, et al.. (2010). Bright light treatment of depressive symptoms in patients with restrictive type of anorexia nervosa. Journal of Affective Disorders. 130(3). 462–465. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chi‐Fa Hung Breakdown of academic impact, for papers by Ida Hageman Breakdown of academic impact, for papers by Nicholas Graham Breakdown of academic impact, for papers by Erin L. Zelinski Breakdown of academic impact, for papers by Joel Erblich Breakdown of academic impact, for papers by Mandana Ashrafi Breakdown of academic impact, for papers by Monika Talarowska Breakdown of academic impact, for papers by Misty Richards Breakdown of academic impact, for papers by Sarah Hartley Breakdown of academic impact, for papers by Glenna Brewster
Rankless by CCL
2026